Overexpression of cyclin D1 in accelerated-phase chronic myeloid leukemia

Jin Hwang Liu*, Chueh Chuan Yen, Yu Chen Lin, Jyh Pyng Gau, Muh Hwa Yang, Ta Chung Chao, Liang Tsai Hsiao, Wei Shu Wang, Ying Chieh Tsai, Po Min Chen


研究成果: Article同行評審

13 引文 斯高帕斯(Scopus)


Chronic myeloid leukemia (CML) is a bi- or triphasic disease. Molecular markers distinct for the phase evolution would be clinically helpful. For signaling transformation and proliferation activities in CML, Bcr-Abl is the pivotal protein. As downstream signals of Bcr-Abl, RAS, PI3-K, and Stat 5 may lead to cell cycle progression mediated by increased expression of cyclin Ds. We analyzed copy numbers of bcr-abl and cyclin D1 transcripts by reverse transcription (RT) and competitive PCR titration in bone marrow cells of 20 patients with CML, 10 in chronic phase (CP) and the other 10 in accelerated phase (AP). The level of bcr-abl transcripts in the AP was not significantly higher than that in the CP; in contrast, the level of cyclin D1 transcripts in the AP was significantly higher than that in the CP (p < 0.001). Cyclin D1 RNA expression in the CP of CML was also found to have clinical relevance to time to AP transformation. The median time to AP transformation for the CP patients with cyclin D1 transcripts of ≥ 1.50 × 104/μg RNA was significantly shorter than that for those with cyclin D1 transcripts < 1.50 × 104/μg RNA (15 vs. 67 months, p = 0.0354) although confirmation to conduct in a larger patient group is required. These results suggest that the expression level of cyclin D1 RNA in bone marrow cells is predictive of the phase evolution in CML and may be helpful in treatment decision-making.

頁(從 - 到)2419-2425
期刊Leukemia and Lymphoma
出版狀態Published - 12月 2004


深入研究「Overexpression of cyclin D1 in accelerated-phase chronic myeloid leukemia」主題。共同形成了獨特的指紋。